首页> 外文OA文献 >Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes

【2h】

Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes

机译：SLCO输送基因在抗阉割前列腺癌中的表达及SLCO1B3和SLCO2B1对前列腺癌结果的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jonathan L. Wright; Erika M. Kwon; Elaine A. Ostrander; R. Bruce Montgomery; Daniel W. Lin; Robert Vessella; Janet L. Stanford; Elahe A. Mostaghel;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer. [J] . Yang M, Xie W, Mostaghel E, Journal of Clinical Oncology . 2011,第18期

机译：SLCO2B1和SLCO1B3可能决定接受前列腺癌雄激素剥夺疗法的患者的进展时间。
2. Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC) [J] . Hahn Andrew W., Gill David M., Poole Austin, Molecular cancer therapeutics . 2019,第3期

机译：SLCO2B1中的种系变体和对醋酸乙酸Abiraterone的反应加上抗泼尼松（AA）在新开始的转移性阉割前列腺癌（MCRPC）中
3. Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer. [J] . Hamada A, Sissung T, Price DK, Clinical cancer research: an official journal of the American Association for Cancer Research . 2008,第11期

机译：SLCO1B3单倍型对白种人雄激素非依赖性前列腺癌患者睾丸激素转运和临床结果的影响。
4. Dietary Omega-3 Fatty Acids, Genetic Variation and Risk of Breast and Prostate Cancers [C] . Julian Mauermann, Frederic Pouliot, Vincent Fradet Inaugural Conference of the World Council on Genetics, Nutrition and Fitness for Health on the theme "Health Agriculture, Healthy Nutrition, Healthy People . 2011

机译：膳食ω-3脂肪酸，遗传变异和乳腺癌和前列腺癌的风险
5. Genetic variation in the androgen receptor impacts prostate cancer initiation and progression in the humanized AR mouse. [D] . Albertelli, Megan A. 2007

机译：雄激素受体的遗传变异影响人源化AR小鼠中前列腺癌的发生和发展。
6. Expression of SLCO transport genes in castration resistant prostate cancer and impact of genetic variation in SCLO1B3 and SLCO2B1 on prostate cancer outcomes [O] . Jonathan L Wright, Erika M Kwon, Elaine A Ostrander, -1

机译：SLCO输送基因在抗阉割前列腺癌中的表达及SCLO1B3和SLCO2B1对前列腺癌结果的影响
7. SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer [O] . Yang, Ming, Xie, Wanling, Mostaghel, Elahe, 2011

机译：SLCO2B1和SLCO1B3可能决定接受前列腺癌雄激素剥夺疗法的患者的进展时间
8. SLCO2B1 and SLCO1B3 as New Targets for Enhancing Androgen Deprivation Therapy for Prostate Cancer. [R] . Kantoff, P. W. 2016

机译：sLCO2B1和sLCO1B3作为增强雄激素剥夺治疗前列腺癌的新靶点。

Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes

著录项

相似文献

相关主题

期刊订阅